Atlas Trials

Could Docosahexaenoic Acid (DHA), Contained in Breast Milk and Artificial Baby Milks, Protect Infants and Children From COVID-19 and Make Them Less Prone to COVID-19-related Severe Illness Than Adults?

Clinical trial NCT05075031 · UNKNOWN

Trial details

NCT number
NCT05075031
Sponsor
Kafrelsheikh University
Status
UNKNOWN
Study type
OBSERVATIONAL
COVID19
Start date
2021-12-01
Primary completion
2022-01-01
Enrollment
1500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.